Patient Telemonitoring Systems Market Revenue and Forecast by 2033


25 Aug 2025

Share : linkedin twitter facebook

The patient telemonitoring systems market is driven by the shift toward value-based care, enabling real-time health tracking and improved patient engagement. The growth of the market is attributed to the increasing prevalence of chronic diseases, growing demand for remote care, and advancements in digital health technologies.

Patient Telemonitoring Systems Market Revenue Statistics

What are the Major Factors Impacting the Growth of the Patient Telemonitoring Systems Market?

The market for telemonitoring systems is experiencing robust growth, driven by a confluence of factors. The rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and respiratory illnesses is increasing the demand for continuous health monitoring solutions outside traditional hospital settings. The rise of digital health solutions, advancements in wireless connectivity, the proliferation of wearable devices, and the integration of Artificial Intelligence (AI) for analytics are influencing market growth. An aging global population is also boosting demand for more cost-effective home care models. Furthermore, a favorable regulatory environment, including government policies that promote telemonitoring and reimbursement for telehealth services, is accelerating the integration of telehealth into mainstream care delivery models. The rising focus on patient-centric care also supports market growth.

Segment Insights

  • By offering/solution type, the hardware-centric solutions segment dominated the market in 2024, driven by the increased demand for advanced monitoring devices, wearable sensors, and medical devices that promote real-time, remote patient care. Hardware solutions, such as wearables, sensors, monitors, and remote-monitoring devices, play an essential role in capturing patients’ physiological data, supporting segmental growth.
  • By clinical function/monitored parameter, the cardiac segment dominated the market in 2024, as cardiovascular diseases (CVDs) remain a global health burden, driving demand for remote monitoring tools that help reduce emergency hospitalizations and improve chronic care.
  • By end-user/buyer, the hospitals & health systems segment contributed the largest market share in 2024, as they are pivotal enablers and integrators of telemonitoring within broader clinical workflows. These settings focus on improving the lives of patients, driving the adoption rate of telemonitoring systems.
  • By deployment model/commercial model, the CapEx device purchase + software license segment led the market in 2024, as hospitals generally prefer to own devices, rather than renting them. In such a setup, healthcare institutions invest upfront (CapEx) to acquire the necessary hardware and secure software licenses, enabling control over data privacy and security.

Regional Insights

North America registered dominance in the patient telemonitoring systems market, capturing the largest share in 2024. This is mainly due to its superior healthcare infrastructure, rapid adoption of digital health technologies, and a high prevalence of chronic diseases. The region benefits from a favorable reimbursement landscape, government initiatives promoting telehealth development, and increasing investments in remote patient monitoring solutions by hospitals and health systems. Growing consumer awareness of connected health, coupled with the presence of major technology companies, will further drive market penetration.

Asia Pacific is likely to witness the fastest growth in the patient telemonitoring systems market, driven by the increasing digitization of healthcare, improvements in connectivity, and government incentives to expand healthcare access in underserved areas. Unhealthy lifestyles, rapid urbanization, and an aging population contribute to a rising prevalence of chronic diseases, which fuels the demand for remote monitoring solutions. The rising adoption of wearable medical devices will further support market growth in the region.

Patient Telemonitoring Systems Market Coverage

Report Attribute Key Statistics
Quantitative Units Revenue in USD billion/trillion, Volume in units
Largest Market North America
Base Year 2024
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Recent Development

  • In April 2025, the PrediHealth project introduced an IoT-based telemedicine telemonitoring kit for chronic heart failure management. This platform features medical devices, environmental sensors, and AI-driven predictive models aimed at reducing hospitalizations and improving care continuity. 
    (Source: https://arxiv.org)

Patient Telemonitoring Systems Market Key Players

  • Philips
  • GE HealthCare
  • Medtronic plc
  • Abbott Laboratories
  • ResMed Inc.
  • Dexcom, Inc.
  • Masimo Corporation
  • Omron Healthcare
  • Biotelemetry / Philips Cardiac Monitoring (Biotelemetry brand)
  • Biofourmis
  • Teladoc Health
  • Athelas (Athelas Inc.)
  • Vivify Health 
  • AliveCor, Inc.
  • Withings (Withings / Nokia Health heritage)
  • Garmin Ltd. (health devices & integrations)
  • VitalConnect, Inc.
  • iRhythm Technologies (Zio cardiac monitoring)
  • Boston Scientific / Preventice 
  • Huma (formerly Medopad)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6632

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344

Related Reports